GeneOne Life Science, Inc.
Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.
011000 | KO
Overview
Corporate Details
- ISIN(s):
- KR7011000007
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 영등포구 여의대로 108 20층(여의도동, 파크원NH금융타워(타워2)), 서울특별시
- Website:
- https://www.genels.com/en/
Description
GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-30 00:00 |
단기차입금증가결정(자율공시)
|
Korean | 8.8 KB | ||
| 2025-04-09 00:00 |
기타안내사항(안내공시)
|
Korean | 7.0 KB | ||
| 2025-04-09 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 14.3 KB | ||
| 2025-04-02 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-04-02 00:00 |
최대주주등소유주식변동신고서
|
Korean | 34.7 KB | ||
| 2025-03-26 00:00 |
정기주주총회결과
|
Korean | 19.0 KB | ||
| 2025-03-18 00:00 |
사업보고서 (2024.12)
|
Korean | 662.5 KB | ||
| 2025-03-14 00:00 |
감사보고서제출
|
Korean | 20.4 KB | ||
| 2025-03-11 00:00 |
주주총회소집공고
|
Korean | 212.7 KB | ||
| 2025-03-11 00:00 |
의결권대리행사권유참고서류
|
Korean | 68.7 KB | ||
| 2025-02-26 00:00 |
주주총회소집결의
|
Korean | 15.3 KB | ||
| 2025-02-12 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 13.9 KB | ||
| 2025-01-17 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.8 KB | ||
| 2025-01-17 00:00 |
최대주주등소유주식변동신고서
|
Korean | 32.8 KB | ||
| 2024-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 3.8 KB |
Automate Your Workflow. Get a real-time feed of all GeneOne Life Science, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GeneOne Life Science, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GeneOne Life Science, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
